WINDTREE THERAPEUTICS INC /DE/ WINT
Biological Products, (No Diagnostic Substances) · CIK 0000946486 · Fiscal year ends 1231
Revenue
$198.00K
Fiscal year ended 2019-12-31Operating income
-$24.89M
Fiscal year ended 2019-12-31Free cash flow
-$24.85M
Fiscal year ended 2019-12-31Valuation, from the filing
| Public float | $1.90M | Market value of stock held by non-affiliates, as stated on the cover page for 2024-06-28 |
|---|
| Float per share | $0.53 | Float divided by shares outstanding in the same filing. A floor under the share price on that date, not the price itself. |
|---|
Every figure here is drawn from the 10-K cover page and the statements behind it, so each one traces to a filing. Public float counts only stock held by non-affiliates, which makes these floors rather than estimates: a high multiple is conclusive, a low one may mean cheap or may mean closely held. The float was measured on 2024-06-28, not today.
How this compares in its industry
Percentile among the Biological Products, (No Diagnostic Substances) filers on this site, highest value first. A high percentile means a large figure, which is good for a margin and not for leverage — the ranking says where the company sits, not whether that is where it should be.
WINDTREE THERAPEUTICS INC /DE/ (WINT) reported revenue of $198.00K and net income of -$27.48M for the fiscal year ended 2019-12-31. This page shows 6 annual periods of income statement, balance sheet and cash flow figures normalized from WINDTREE THERAPEUTICS INC /DE/’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Biological Products, (No Diagnostic Substances).
Income
Balance
Cash flow
Derived
WINDTREE THERAPEUTICS INC /DE/ derived by fiscal year, in US dollars, normalized from SEC filings.| Metric | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 |
|---|
| Free cash flow | -$24.85M | —Unavailable | -$21.07M | -$33.87M | —Unavailable | —Unavailable |
|---|
| Gross margin | —Unavailable | —Unavailable | —Unavailable | —Unavailable | 5.9% | 5.8% |
|---|
| Operating margin | -12572.2% | -905.8% | -1518.4% | -1862.7% | -4035.9% | -1525.9% |
|---|
| FCF margin | -12552.5% | —Unavailable | -1418.8% | -1658.7% | —Unavailable | —Unavailable |
|---|
| SBC / revenue | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable |
|---|
| Current ratio | 3.05x | 1.24x | 0.19x | 0.54x | 3.69x | 5.82x |
|---|
| Revenue YoY growth | -88.9% | 20.4% | -27.3% | 106.9% | -65.2% | —Unavailable |
|---|
| Net margin | -13876.3% | -1148.4% | -1242.2% | -1933.9% | -5589.7% | -1554.1% |
|---|
| R&D / revenue | 6407.6% | 590.7% | 1170.1% | 1552.6% | 2926.8% | 941.4% |
|---|
| CapEx / revenue | 96.5% | —Unavailable | 1.6% | 13.8% | 46.4% | 27.5% |
|---|
| Long-term debt / equity | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable |
|---|
| Effective tax rate | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable |
|---|
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open WINT in the interactive workspace to inspect any figure back to its filing.
Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.